Résultats de la recherche - Nicole J. Ullrich
- Résultat(s) 1 - 20 résultats de 35
- Aller à la page suivante
-
1
-
2
-
3
-
4
-
5
Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression par Ning Lin, Lissa Baird, McKenzie Koss, Kimberly Kopecky, Evelyne Gone, Nicole J. Ullrich, R. Michael Scott, Edward R. Smith
Publié 2011Artigo -
6
Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey par Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan
Publié 2025Artigo -
7
-
8
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities par Laura J. Klesse, Justin T. Jordan, Heather B. Radtke, Tena Rosser, Elizabeth K. Schorry, Nicole J. Ullrich, David Viskochil, Pamela Knight, Scott R. Plotkin, Kaleb Yohay
Publié 2020Revisão -
9
Peripheral neuropathy in children and adolescents treated for cancer par Kari Bjornard, Laura Gilchrist, Hiroto Inaba, B Diouf, Marilyn Hockenberry, Nina S. Kadan‐Lottick, Daniel C. Bowers, M. Eileen Dolan, Nicole J. Ullrich, William E. Evans, Kirsten K. Ness
Publié 2018Revisão -
10
Functional outcome measures for NF1-associated optic pathway glioma clinical trials par Michael J. Fisher, Robert A. Avery, Jeffrey C. Allen, Simone Ardern‐Holmes, Larissa T. Bilaniuk, Rosalie E. Ferner, David H. Gutmann, Robert Listernick, Staci Martin, Nicole J. Ullrich, Grant T. Liu
Publié 2013Artigo -
11
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas par Regina I. Jakacki, Eva Dombi, Seth M. Steinberg, Stewart Goldman, Mark W. Kieran, Nicole J. Ullrich, Ian F. Pollack, Anne Goodwin, Peter Manley, Jason Fangusaro, Rudy Allen, Brigitte C. Widemann
Publié 2016Artigo -
12
Long‐term clinical outcomes following treatment of childhood craniopharyngioma par Karen M. Winkfield, Henry Tsai, Xiaopan Yao, Elysia Larson, Donna Neuberg, Scott L. Pomeroy, Nicole J. Ullrich, Laurie E. Cohen, Mark W. Kieran, R. Michael Scott, Liliana Goumnerova, Karen J. Marcus
Publié 2010Artigo -
13
Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database par Pratiti Bandopadhayay, Guillaume Bergthold, Wendy B. London, Liliana Goumnerova, Andrés Morales La Madrid, Karen J. Marcus, Dongjing Guo, Nicole J. Ullrich, Nathan Robison, Susan Chi, Rameen Beroukhim, Mark W. Kieran, Peter Manley
Publié 2014Artigo -
14
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report par Elizabeth Wells, Nicole J. Ullrich, Kristy Seidel, Wendy M. Leisenring, Charles A. Sklar, Gregory T. Armstrong, Lisa Diller, Allison A. King, Kevin R. Krull, Joseph P. Neglia, Marilyn Stovall, Kimberly Whelan, Kevin C. Oeffinger, Leslie L. Robison, Roger J. Packer
Publié 2017Artigo -
15
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study par Brian Weiss, Brigitte C. Widemann, Pamela L. Wolters, Eva Dombi, Alexander A. Vinks, Alan Cantor, John P. Perentesis, Elizabeth K. Schorry, Nicole J. Ullrich, David H. Gutmann, J. Tonsgard, David Viskochil, Bruce R. Korf, Roger J. Packer, Michael J. Fisher
Publié 2014Artigo -
16
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival par Amanda Marinoff, Clement Ma, Dongjing Guo, Matija Snuderl, Karen Wright, Peter Manley, Hasan Al‐Sayegh, Claire Sinai, Nicole J. Ullrich, Karen J. Marcus, Daphne A. Haas‐Kogan, Liliana Goumnerova, Wendy B. London, Mark W. Kieran, Susan Chi, Jason Fangusaro, Pratiti Bandopadhayay
Publié 2017Artigo -
17
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis par MJ Fisher, Michael J. Loguidice, David H. Gutmann, Robert Listernick, Rosalie E. Ferner, Nicole J. Ullrich, R. J. Packer, Uri Tabori, Robert Hoffman, Simone Ardern‐Holmes, Trent R. Hummel, Darren Hargrave, Éric Bouffet, Joel Charrow, Larissa T. Bilaniuk, Laura J. Balcer, G. T. Liu
Publié 2012Artigo -
18
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study par Allison A. King, Kristy Seidel, Chongzhi Di, Wendy M. Leisenring, Stephanie M. Perkins, Kevin R. Krull, Charles A. Sklar, Daniel M. Green, Gregory T. Armstrong, Lonnie K. Zeltzer, Elizabeth Wells, Marilyn Stovall, Nicole J. Ullrich, Kevin C. Oeffinger, Leslie L. Robison, Roger J. Packer
Publié 2016Artigo -
19
Multicenter, prospective, phase 2 study of maintenance bevacizumab for children and adults with <i>NF2</i>-related schwannomatosis and progressive vestibular schwannoma par Scott R. Plotkin, Jeffrey C. Allen, Girish Dhall, Jian L. Campian, D. Wade Clapp, Michael J. Fisher, Rakesh K. Jain, James H. Tonsgard, Nicole J. Ullrich, Coretta Thomas, Lloyd J. Edwards, Bruce R. Korf, Roger J. Packer, Matthias A. Karajannis, Jaishri O. Blakeley
Publié 2023Artigo -
20
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma par Scott R. Plotkin, Dan G. Duda, Alona Muzikansky, Jeffrey C. Allen, Jaishri O. Blakeley, Tena Rosser, Jian L. Campian, D. Wade Clapp, Michael J. Fisher, James H. Tonsgard, Nicole J. Ullrich, Coretta Thomas, Gary Cutter, Bruce R. Korf, Roger J. Packer, Matthias A. Karajannis
Publié 2019Artigo
Outils de recherche:
Sujets similaires
Medicine
Internal medicine
Neurofibromatosis
Pathology
Biology
Pediatrics
Surgery
Biochemistry
Gene
Clinical trial
Oncology
Psychiatry
Chemotherapy
Gastroenterology
Neurofibromatosis type 2
Chemistry
Cohort
Genetics
Radiology
Cancer
Cancer research
Confidence interval
Environmental health
Incidence (geometry)
Optics
Phenotype
Physics
Population
Progeria
Proportional hazards model